About

Company description

Hovione has 60 years of experience as a CDMO and is a fully integrated supplier offering services for drug substance, drug product intermediate and drug product. With four FDA inspected sites in the USA, China, Ireland and Portugal and development laboratories in Portugal and USA, the company provides branded pharmaceutical customers services for the development and compliant manufacture of innovative drugs including highly potent compounds. 

Hovione offers a full range of development services and manufacturing capacity in particle engineering (Spray Drying, Spray Congealing, Hot Melt Extrusion, Jet Milling, Nanoparticles and Wet Polishing) to provide optimal solutions for your drug product with the right scale and flexibility. For generic pharmaceutical customers the company offers niche API products. Hovione also provides proprietary product development and licensing opportunities for drug products. In the inhalation area, Hovione is the only independent company offering a complete range of services.  Please visit www.hovione.com

Quick facts

Sales markets Western Europe; Middle East; Asia; Australia; North America
Affiliated categories: Aerosols |API Contract Manufacturing |Bioavailability enhancement More

Upcoming events

13 oct 2020

CPhI Worldwide 2020

13 - 15 October 2020 Milan, Italy Visit us at stand 2C30 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 101B60 See our Exhibitor Profile   See full Exhibitor List
18 mar 2019

CPhI Japan 2019

18 - 20 March 2019 Tokyo, Japan We were at stand K-16, 2A-20 See our Exhibitor Profile   See full Exhibitor List

Our Top products

Hydrocortisone Valerate

Hydrocortisone Valerate

Hydrocortisone Valerate

More info
Salbutamol

Salbutamol

Salbutamol

More info
Hydrocortisone Aceponate

Hydrocortisone Aceponate

Hydrocortisone Aceponate

More info
View all our products (46)

News about Hovione

The Leader in Spray Drying

29 Oct 2019

The Leader in Spray Drying

Hovione continues to lead in Spray Drying, thanks to the largest capacity, the most experienced team of scientists that keep coming up with innovative solutions and the best-scale up science.

Read more

15 Apr 2019

Hovione Technology acquires global rights to new pulmonary inhaler device

The Papillon DPI is a single-part, blister-based, reusable inhaler, suitable for both chronic and acute treatments.

Read more

22 Oct 2018

Hovione increases oral dosage production capacity

‘One Site Shop’ expands to respond to growing demands.

Read more

21 Mar 2018

Hovione expansion provides integrated full-service solution

Additional capacity expansion across several of the company's sites also strengthens the company's global market leadership in spray drying.

Read more